Average Co-Inventor Count = 4.42
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (4 from 1,151 patents)
2. Amunix Operating Inc. (4 from 24 patents)
3. Catalyst Biosciences, Inc. (3 from 26 patents)
11 patents:
1. 12331334 - Modified urokinase-type plasminogen activator polypeptides and methods of use
2. 12173337 - Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
3. 11807882 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
4. 11613744 - Modified urokinase-type plasminogen activator polypeptides and methods of use
5. 11401513 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
6. 10954501 - Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
7. 10781435 - Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
8. 9938331 - Biologically active proteins having increased in vivo and/or in vitro stability
9. 8492530 - Unstructured recombinant polymers and compositions comprising same
10. 7855279 - Unstructured recombinant polymers and uses thereof
11. 7846445 - Methods for production of unstructured recombinant polymers and uses thereof